[Is conventional heterosexual hormone therapy in metastasizing prostate cancer still justified?].
D001859:Bone Neoplasms / Q000556:secondary*; D002277:Carcinoma / Q000188:drug therapy* / Q000401:mortality; D004967:Estrogens / Q000008:administration & dosage*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D012189:Retrospective Studies; D013557:Switzerland
D004967:Estrogens
Ist die konventionelle heterosexuelle Therapie beim metastasierenden Prostatakarzinom noch berechtigt?